March 10, 2027

Diagnostics Forum – The exclusive diagnostics industry event

Content on this page

Exciting industry trends and exclusive insights

March 10, 2027 Where the diagnostics industry comes together

The diagnostics industry is rapidly evolving. The Diagnostics Forum brings together leading experts and decision-makers at our headquarters in Schwäbisch Hall, Germany, to focus on the innovations, trends, and challenges shaping the future of diagnostics.

Why attend the Diagnostics Forum
in 60 seconds:

International keynotes

Hear from renowned guest speakers from industry, research, and healthcare. Look forward to insightful presentations on topics such as personalized cancer therapies, regulatory requirements, flexible and scalable manufacturing solutions, as well as current trends and challenges in in vitro diagnostics.

Exclusive shop-floor tour

Take a behind-the-scenes look at Optima. Through live demonstrations and a guided tour of our assembly areas, you will experience our state-of-the-art diagnostics solutions up close. Our Diagnostics team will provide practical insights into the latest developments and technology concepts shaping the industry.

Many people at round tables during an evening event for a customer event

Curated networking

Connect with industry peers, experts, and decision-makers from the global diagnostics sector. Benefit from direct exchange, gain fresh perspectives for your projects, and build valuable professional relationships. Conclude the day at an exclusive evening event and continue the conversation in a relaxed setting.

March 10, 2027
One day. Advanced diagnostics. New perspectives.

International keynotes

The official event and presentation language is English.

Dr. Sebastian Köber
QIAGEN

Associate Director, Process Technologies
Presentation:
Stabilization and improvement of diagnostic manufacturing processes

Prof. Dr. Michael Schmitt
Heidelberg University Hospital Siebeneicher Professor of Cellular Immunotherapy
Head of the GMP Core Facility
Qualified person pursuant to Section 14 of the German Medicines Act (AMG)
Presentation:
Precision medicine against cancer: Antigen-specific treatment with immune cells